BetterLife Pharma Inc. (OTCMKTS:BETRF) Sees Significant Decrease in Short Interest

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 14,500 shares, a drop of 41.5% from the February 28th total of 24,800 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 15,800 shares, the short-interest ratio is presently 0.9 days.

BetterLife Pharma Price Performance

Shares of BETRF stock traded down $0.01 during mid-day trading on Friday, hitting $0.06. The company had a trading volume of 1,500 shares, compared to its average volume of 17,616. The company has a market capitalization of $7.61 million, a P/E ratio of -1.96 and a beta of 1.41. The stock’s 50 day moving average price is $0.08 and its 200-day moving average price is $0.08. BetterLife Pharma has a 52-week low of $0.05 and a 52-week high of $0.15.

BetterLife Pharma Company Profile

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.